Intercure (INCR) Earnings Date & Reports

Industry: @Servicestothe Health Industry

A.I. Advisor

published Earnings

INCR is expected to report earnings to rise 197.74% to -10 cents per share on August 26

Q2'24

Est.

$-0.11

Q1'24

Beat

by $0.08

Q4'23

Missed

by $0.30

Q3'23

Est.

$-0.01

Q2'23

Beat

by $0.01

The last earnings report on May 13 showed earnings per share of -3 cents, beating the estimate of -11 cents. With 9.17K shares outstanding, the current market capitalization sits at 123.50M.

View a ticker or compare two or three

Compare

INCR

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For INCR
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a provider of outsourced clinical development and commercialization services to biopharmaceutical companies

Industry PharmaceuticalsOther

Profile

Fundamentals

Details

Industry

Servicestothe Health Industry

Address

85 Medinat ha-Yehudim Street

Phone

+972 774605012

Employees

370

Web

https://www.intercure.co